Cognition Therapeutics, Inc.
CGTX
$1.01
-$0.03-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.96% | -36.70% | 32.19% | 26.79% | 20.59% |
| Total Depreciation and Amortization | -19.12% | 11.48% | 0.00% | 0.00% | 35.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.04% | -16.04% | -23.56% | -15.94% | 5.97% |
| Change in Net Operating Assets | 138.25% | -148.19% | 57.52% | -403.96% | 121.15% |
| Cash from Operations | 44.91% | -61.25% | 39.18% | -0.50% | 43.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.65% | -52.70% | -80.49% | 65.83% | -1.69% |
| Issuance of Common Stock | 15,211.36% | -98.53% | -91.17% | 3,776.17% | -39.93% |
| Repurchase of Common Stock | 93.29% | -112.99% | -113.89% | -620.00% | 89.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,936.91% | -138.51% | -98.22% | 4,410.24% | -41.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.25% | -104.57% | -109.99% | 680.29% | 43.24% |